CARSGEN THERAPEUTICS HLDGS LTD revenue breakdown overview

CARSGEN THERAPEUTICS HLDGS LTD revenue for the last year amounted to 41.96 M HKD, the most of which — 42.75 M HKD — came from its highest performing source at the moment, CAR T-cell Therapies, the year earlier bringing 31.11 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought CARSGEN THERAPEUTICS HLDGS LTD 42.75 M HKD.